183 related articles for article (PubMed ID: 30100330)
21. Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study.
Lazzarotto D; Tanasi I; Vitale A; Piccini M; Dargenio M; Giglio F; Forghieri F; Fracchiolla N; Cerrano M; Todisco E; Papayannidis C; Leoncin M; Defina M; Guolo F; Pasciolla C; Delia M; Chiusolo P; Mulè A; Candoni A; Bonifacio M; Pizzolo G; Foà R
Ann Hematol; 2023 May; 102(5):1099-1109. PubMed ID: 36959485
[TBL] [Abstract][Full Text] [Related]
22. Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML.
Jentzsch M; Bill M; Grimm J; Brauer D; Backhaus D; Goldmann K; Schulz J; Niederwieser D; Platzbecker U; Schwind S
Ann Hematol; 2020 Oct; 99(10):2417-2427. PubMed ID: 32862286
[TBL] [Abstract][Full Text] [Related]
23. Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study.
Lachowiez CA; Reville PK; Kantarjian H; Jabbour E; Borthakur G; Daver N; Loghavi S; Furudate K; Xiao L; Pierce S; Short NJ; Maiti A; Yilmaz M; Sasaki K; Takahashi K; Konopleva M; Pemmaraju N; Popat U; Shpall E; Garcia-Manero G; Ravandi F; DiNardo CD; Kadia TM
Lancet Haematol; 2022 May; 9(5):e350-e360. PubMed ID: 35483396
[TBL] [Abstract][Full Text] [Related]
24. Myeloblative therapy with autologous haematopoietic stem cell support as consolidation of first remission in acute myeloid leukaemia - very long follow-up.
Rohatiner AZ; Smith ML; Spinelli O; Rambaldi A; Bassan R; di Bona E; Rodeghiero F; Raimondi R; Björkholm M; Johnson S; Newland AC; Cavenagh JD; Macdougall F; Waters R; Fitzgibbon J; Barbui T; Lister A
Br J Haematol; 2014 Dec; 167(5):724-6. PubMed ID: 25074579
[No Abstract] [Full Text] [Related]
25. [Efficacy of Activated Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia].
Ren RR; Ma LM; Wang T; Xie YX; Zhu QJ; Gao ZL; Tian WW; Gong R; Niu YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(5):1509-1515. PubMed ID: 37846709
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of complex and/or monosomal karyotypes in post-transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach.
Jo T; Arai Y; Oshima S; Kondo T; Harada K; Uchida N; Doki N; Fukuda T; Tanaka M; Ozawa Y; Kuriyama T; Ikegame K; Katayama Y; Ota S; Ara T; Kawakita T; Onizuka M; Ichinohe T; Atsuta Y; Yanada M;
Br J Haematol; 2023 Jul; 202(2):356-368. PubMed ID: 37211753
[TBL] [Abstract][Full Text] [Related]
27. Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantation.
Eyre TA; Barrington SF; Okosun J; Abamba C; Pearce RM; Lee J; Carpenter B; Crawley CR; Bloor AJC; Gilleece M; Nicholson E; Shah N; Orchard K; Malladi R; Townsend WM
Haematologica; 2023 Mar; 108(3):785-796. PubMed ID: 35586966
[TBL] [Abstract][Full Text] [Related]
28. Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia.
Tschernia NP; Kumar V; Moore DT; Vincent BG; Coombs CC; Van Deventer H; Foster MC; DeZern AE; Luznik L; Riches ML; Serody JS; Gojo I; Zeidner JF
Transplant Cell Ther; 2021 Dec; 27(12):1021.e1-1021.e5. PubMed ID: 34474164
[TBL] [Abstract][Full Text] [Related]
29. Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation.
Bazinet A; Kantarjian H; Arani N; Popat U; Bataller A; Sasaki K; DiNardo CD; Daver N; Yilmaz M; Abbas HA; Short NJ; Issa G; Jabbour E; Pierce SA; Chen J; Garcia R; Konopleva M; Garcia-Manero G; Alousi A; Shpall EJ; Champlin RE; Borthakur G; Ravandi F; Kadia T
Am J Hematol; 2023 Sep; 98(9):1383-1393. PubMed ID: 37334870
[TBL] [Abstract][Full Text] [Related]
30. [Observation on the efficacy of consolidation chemotherapy combined with allogeneic natural killer cell infusion in the treatment of low and moderate risk acute myeloid leukemia].
Wang CJ; Huang XJ; Gong LZ; Jia JS; Liu XH; Wang Y; Yan CH; Chang YJ; Zhao XS; Shi HX; Lai YY; Jiang H
Zhonghua Xue Ye Xue Za Zhi; 2019 Oct; 40(10):812-817. PubMed ID: 31775478
[No Abstract] [Full Text] [Related]
31. Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.
Rothenberg-Thurley M; Amler S; Goerlich D; Köhnke T; Konstandin NP; Schneider S; Sauerland MC; Herold T; Hubmann M; Ksienzyk B; Zellmeier E; Bohlander SK; Subklewe M; Faldum A; Hiddemann W; Braess J; Spiekermann K; Metzeler KH
Leukemia; 2018 Jul; 32(7):1598-1608. PubMed ID: 29472724
[TBL] [Abstract][Full Text] [Related]
32. Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study.
Baranwal A; Chhetri R; Yeung D; Clark M; Shah S; Litzow MR; Hogan WJ; Mangaonkar A; Alkhateeb HB; Singhal D; Cibich A; Bardy P; Kok CH; Hiwase DK; Shah MV
Bone Marrow Transplant; 2023 Jul; 58(7):769-776. PubMed ID: 37012415
[TBL] [Abstract][Full Text] [Related]
33. Post-remission measurable residual disease directs treatment choice and improves outcomes for patients with intermediate-risk acute myeloid leukemia in CR1.
Han L; Li Y; Wu J; Peng J; Han X; Zhao H; He C; Li Y; Wang W; Zhang M; Li Y; Sun H; Cao H; Sang L; Jiang Z; Yu J
Int J Hematol; 2022 Dec; 116(6):892-901. PubMed ID: 36031670
[TBL] [Abstract][Full Text] [Related]
34. Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplant.
Solomon SR; Solh M; Morris LE; Holland HK; Bachier-Rodriguez L; Zhang X; Guzowski C; Jackson KC; Brown S; Bashey A
Blood Adv; 2023 Sep; 7(18):5215-5224. PubMed ID: 37379271
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis.
Poon ML; Fox PS; Samuels BI; O'Brien S; Jabbour E; Hsu Y; Gulbis A; Korbling M; Champlin R; Abruzzo LV; Bassett RL; Khouri IF
Leuk Lymphoma; 2015 Mar; 56(3):711-5. PubMed ID: 24913509
[TBL] [Abstract][Full Text] [Related]
36. Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experience and current challenges.
Capria S; Trisolini SM; Diverio D; Minotti C; Breccia M; Cartoni C; Carmini D; Gozzer M; La Rocca U; Shafii Bafti M; Martelli M
Int J Hematol; 2022 Oct; 116(4):586-593. PubMed ID: 35551633
[TBL] [Abstract][Full Text] [Related]
37. Genetic landscape and clinical outcomes of patients with
Baranwal A; Gurney M; Basmaci R; Katamesh B; He R; Viswanatha DS; Greipp P; Foran J; Badar T; Murthy H; Yi CA; Palmer J; Mangaonkar AA; Patnaik MM; Litzow MR; Hogan WJ; Begna K; Gangat N; Tefferi A; Al-Kali A; Shah MV; Alkhateeb HB
Haematologica; 2024 Jun; 109(6):1779-1791. PubMed ID: 38299584
[TBL] [Abstract][Full Text] [Related]
38. The prognostic benefit from intermediate-dose cytarabine as consolidation therapy varies by cytogenetic subtype in t(8;21) acute myeloid leukemia: a retrospective cohort study.
Chen G; Yang J; Cao F; Zhou W; Gong D; Liu L; Zhou D
Ann Transl Med; 2022 Aug; 10(16):858. PubMed ID: 36111020
[TBL] [Abstract][Full Text] [Related]
39. Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration.
Hammer ASB; Juul-Dam KL; Sandahl JD; Abrahamsson J; Czogala M; Delabesse E; Haltrich I; Jahnukainen K; Kolb EA; Kovács G; Leverger G; Locatelli F; Masetti R; Noren-Nyström U; Raimondi SC; Rasche M; Reinhardt D; Taki T; Tomizawa D; Zeller B; Hasle H; Kjeldsen E
Blood Adv; 2023 Mar; 7(6):1045-1055. PubMed ID: 36332007
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal Patient Reported Outcomes with CAR-T Cell Therapy Versus Autologous and Allogeneic Stem Cell Transplant.
Sidana S; Dueck AC; Thanarajasingam G; Griffin JM; Thompson C; Durani U; Burtis M; Warsame R; Paludo J; Gertz MA; Dispenzieri A; Ansell SM; Rajkumar SV; Yost K; Bennani N; Lin Y; Kumar S
Transplant Cell Ther; 2022 Aug; 28(8):473-482. PubMed ID: 35550440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
